Table of Contents PART 01: Executive summary PART 02: Scope of  the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Market segmentation  by product Angioplasty balloons market Vascular closure device Vascular guidewire Embolic protection devices PART 07: Market segmentation by end user ASCs Hospitals Physicians' offices PART 08: Geographical segmentation Angiography devices market in Americas Angiography devices market in EMEA Angiography devices market in APAC PART 09: Market drivers Rising incidences of cardiac diseases increasing adoption of angiography devices Presence of specialized cardiologists Outsourcing research to CROs Venture capitals for market entry of start-ups Minimally invasive procedures with improved medical imaging PART 10: Impact of drivers PART 11: Market challenges High cost of angiography devices and procedures Product recalls Lack of product differentiation leading to marginal profits PART 12: Impact of drivers and challenges PART 13: Market trends Transforming marketing and sales strategies Increase in M&A Emergence of digital cath labs in hospitals PART 14: Vendor landscape Competitive landscape analysis PART 15: Key vendor analysis Abbott Laboratories Boston Scientific Cardinal Health Medtronic Key companies to watch Other prominent vendors PART 16: Appendix5 List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global angiography devices market: Overview Exhibit 03: Angioplasty devices market by product type 2016 Exhibit 04: Scope of angiography devices market based on geography 2017-2021 Exhibit 05: Global angiography devices market: Impact assessment Exhibit 06: Global angiography devices market 2016-2021 ($ billions) Exhibit 07: Few key market developments Exhibit 08: Five forces analysis Exhibit 09: Global angiography devices market by product 2016-2021 ($ billions) Exhibit 10: Market overview: Angioplasty balloon Exhibit 11: Key focus and strategies of companies: Angioplasty balloon Exhibit 12: Global angioplasty balloons market 2016-2021 ($ billions) Exhibit 13: Clinical study: Difference in stenosis of DEBs Exhibit 14: Market overview: Vascular closure device Exhibit 15: Key focus and strategies of companies: Vascular closure device Exhibit 16: Global vascular closure devices market 2016-2021 ($ billions) Exhibit 17: Market overview and focus of companies: Vascular guidewire Exhibit 18: Key focus and strategies of companies: Vascular guidewire Exhibit 19: Global vascular guidewires market 2016-2021 ($ billions) Exhibit 20: Market overview and focus of companies: Embolic protection device Exhibit 21: Key focus and strategies of companies: Embolic protection device Exhibit 22: Global embolic protection devices market 2016-2021 ($ billions) Exhibit 23: Some advanced embolic protection devices Exhibit 24: New entrants and milestone achieved by them Exhibit 25: Embolic protection devices: Clinical studies with positive results Exhibit 26: Global angiography devices market in 2016 Exhibit 27: Comparison of reimbursement for ASCs, hospital out-patient departments, and physicians' offices in US Exhibit 28: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe Exhibit 29: Global angiography devices market by geography in 2016 and 2021 ($ billions) Exhibit 30: Market overview: Angiography devices market in Americas Exhibit 31: Number of coronary angiography in few countries in Americas 2013 Exhibit 32: Angiography devices market in Americas 2016-2021 ($ billions) Exhibit 33: Angiography devices market in Americas: Metrics analysis for various countries Exhibit 34: Market overview: Angiography devices market in the US Exhibit 35: Implements amended in ACA in US (in 2010 and 2014-2015) Exhibit 36: Impact of Accountable Care Organization (ACO) and ACA on angiography devices Exhibit 37: Market overview: Angiography devices market in EMEA Exhibit 38: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013 Exhibit 39: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013 (in 100,000 population) Exhibit 40: Angiography devices market in EMEA 2016-2021 ($ billions) Exhibit 41: Angiography devices market in EMEA: Metrics analysis by countries Exhibit 42: Market overview: Angiography devices market in Israel Exhibit 43: Market overview: Angiography devices market in APAC Exhibit 44: Angiography devices market in APAC 2016-2021 ($ billions) Exhibit 45: Market overview: Angiography devices market in India Exhibit 46: CROs that helped companies receive regulatory approvals for PCI devices Exhibit 47: CROs that helped companies receive regulatory approvals for PCI devices Exhibit 48: New market entrants Exhibit 49: Impact of drivers Exhibit 50: Product recalls: Angiography devices Exhibit 51: Impact of drivers and challenges Exhibit 52: Marketing and sales strategies of large and small companies Exhibit 53: Acquisitions by some companies Exhibit 54: Competitive structure analysis of global angiography devices market 2016 Exhibit 55: Competitive landscape analysis of global angiography devices market 2016 Exhibit 56: Abbott Laboratories: Strength assessment Exhibit 57: Abbott Laboratories: Strategy assessment Exhibit 58: Abbott Laboratories: Opportunity assessment Exhibit 59: Boston Scientific: Strength assessment Exhibit 60: Boston Scientific: Strategy assessment Exhibit 61: Boston Scientic: Opportunity assessment Exhibit 62: Cardinal Health: Strength assessment Exhibit 63: Cardinal Health: Strategy assessment Exhibit 64: Cardinal Health: Opportunity assessment Exhibit 65: Medtronic: Strength assessment Exhibit 66: Medtronic: Strategy assessment Exhibit 67: Medtronic: Opportunity assessment Exhibit 68: Key companies to watch Exhibit 69: Other prominent vendors

Abbott Laboratories, Boston Scientific, Cardinal Health, Medtronic, Abiomed, Aachen Resonance, Acrostak, Advansource Biomaterials, AGA Medical, Allium Medical, Alvimedica Medical devices, AMG International, Angioslide, AngioDynamics, Arstasis, Arthesys, Asahi Intecc, Atrium Medical, AV Medical, B. Braun Melsungen, Beijing Puyishengji Medical Technology, Biophan Technologies, Biosense Webster, Biotronik, BrosMed, Cardiac Science, CardiacAssist, Cardica, Cardio-Flow, Cardionovum, Claret Medical, Contego Medical, Cook, Cryolife, Endocor, Edward Lifesciences, Essential Medical, GaltNeedleTech, Kaneka Medix, InSeal Medical, Innovative Cardiovascular Solutions, JOTEC, Keystone Heart, Lepu Medical Technology, Medinol, Medeon Biodesign, Morris Innovative, Merit Medical Systems, Meril Life Sciences, MicroPort Scientific, Natec Medical, OptiMed, QT Vascular, SHOCKWAVE Medical, Smiths Medical, Spectranetics, STENTYS, Svelte medical, Teleflex, Tokai Medical, Transverse Medical, Transluminal Technologies, US Endovascular, Vascular Closure Systems, Vasorum, Vivasure Medical, Volcano.